Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 13, 2026Asian Pacific Journal of Tropical BiomedicineOpen Access

Non-psychotropic cannabinoids in pain management: A comprehensive review of mechanisms, clinical evidence, and therapeutic potential

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMaha Jamal

Discussion

Loading...

Member takes

Overview

This review examines non-psychotropic cannabinoids for pain relief in chronic pain, suggesting promising therapeutic options.

Key Points

  • Evaluate the effectiveness of non-psychotropic cannabinoids for pain management and their underlying mechanisms.
  • Comprehensive review of existing preclinical and clinical studies
  • Assessment of cannabinoids' interactions with the endocannabinoid system
  • Discussion of therapeutic challenges and potential alternatives
  • Non-psychotropic cannabinoids show promise in pain modulation without psychoactive effects
  • Preclinical evidence supports their analgesic properties
  • Challenges include product standardization and need for further clinical validation

Cite This Study

Maha Jamal (2026) studied this question.

synapsesocial.com/papers/69dc88d83afacbeac03eaa0bhttps://doi.org/10.4103/apjtb.apjtb_634_25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Cannabinoids in Chronic Pain Management: A Pharmacodynamic Perspective2025 · 2 citations
  2. 2The clinical use of cannabinoids for pain2024 · 1 citations
  3. 3Cannabinoids in Chronic Pain: Clinical Outcomes, Adverse Effects and Legal Challenges2025 · 13 citations
  4. 4Mitigating the Opioid Epidemic: The Role of Cannabinoids in Chronic Pain Management—A Systematic Review and Meta-Analysis of Clinical Evidence and Mechanisms2024
  5. 5Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes2025 · 7 citations